Search Results 291-300 of 17028 for pharmacogenetics
About this study. The study will be performed in two phases: Phase I will be performed for biologic validation of marker candidates from a discovery cohort ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Participants provide their family health history for the conditions studied in the eMERGE phase 4 study. To do this, they use the online MeTree tool created ...
About this study. The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS), in addition to the standard ...
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
The purpose of this study is to build a Mayo Clinic registry of data and biobank from subjects with drug allergy. The data collected will include demographic, ...
Rochester, Minn. The primary purpose/objective of this study is to determine whether myectomy as a management option for severe hypertrophic cardiomyopathy (HCM) ...
Research teams combine multi-omic technologies and data to develop precision diagnostics and therapeutics for patients with various types of cancers, rare ...
Drugs used in chemotherapy, such as carboplatin, cisplatin, and etoposide, work in different ways to stop the growth of tumor cells, either by killing the cells ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.